Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy

…, J Louahed, B Dizier, O Gruselle… - Journal of Clinical …, 2013 - ascopubs.org
Purpose To detect a pretreatment gene expression signature (GS) predictive of response to
MAGE-A3 immunotherapeutic in patients with metastatic melanoma and to investigate its …

Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study

…, J Allen, A Falsey, JY Pirçon, O Gruselle… - European …, 2021 - Eur Respiratory Soc
Background Respiratory syncytial virus (RSV) infection in older adults is recognised as an
important health issue. We aimed to assess the community burden of RSV in Europe in older …

Incidence of respiratory syncytial virus lower respiratory tract infections during the first 2 years of life: a prospective study across diverse global settings

…, JA Englund, S Gandhi, O Gruselle… - The Journal of …, 2022 - academic.oup.com
Background The true burden of lower respiratory tract infections (LRTIs) due to respiratory
syncytial virus (RSV) remains unclear. This study aimed to provide more robust, multinational …

Clinical and viral factors associated with disease severity and subsequent wheezing in infants with respiratory syncytial virus infection

…, D O'connor, MD Snape, O Gruselle… - The Journal of …, 2022 - academic.oup.com
Respiratory syncytial virus (RSV) causes substantial morbidity and mortality in infants and
young children worldwide. Here we evaluated host demographic and viral factors associated …

Performance assessment of a rapid molecular respiratory syncytial virus point-of-care test: a prospective community study in older adults

…, N Adriaenssens, S Coenen, O Gruselle… - The Journal of …, 2022 - academic.oup.com
Background Respiratory syncytial virus (RSV) causes a substantial burden in older adults.
Viral load in RSV-infected adults is generally lower compared to young children, which could …

Evaluation of clinical case definitions for respiratory syncytial virus lower respiratory tract infection in young children

…, L Cousin, S Gandhi, O Gruselle… - Journal of the …, 2023 - academic.oup.com
Background Various case definitions of respiratory syncytial virus lower respiratory tract
infection (RSV-LRTI) are currently proposed. We assessed the performance of 3 clinical case …

Gene expression of MAGE‐A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non–small cell lung cancer patients

…, N Kusuma, NF Delahaye, O Gruselle… - Asia‐Pacific Journal …, 2017 - Wiley Online Library
Aim To determine the frequency of expression of the tumor‐associated antigens (TAAs)
melanoma‐associated antigen A3 (MAGE‐A3) and preferentially expressed antigen of …

Leveraging influenza virus surveillance from 2012 to 2015 to characterize the burden of respiratory syncytial virus disease in Canadian adults≥ 50 years of age …

…, W Bowie, MP David, O Gruselle… - Open Forum …, 2023 - academic.oup.com
Background Respiratory syncytial virus (RSV) disease in older adults is undercharacterized.
To help inform future immunization policies, this study aimed to describe the disease …

[HTML][HTML] The prevalence of expression of MAGE-A3 and PRAME tumor antigens in East and South East Asian non-small cell lung cancer patients

S Thongprasert, PC Yang, JS Lee, R Soo, O Gruselle… - Lung Cancer, 2016 - Elsevier
Introduction Treatment of non-small cell lung cancer (NSCLC) is an important and often
unmet medical need regardless of the disease stage at the time of first diagnosis. Antigen-…

[HTML][HTML] Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons

…, C Verheust, N Dezutter, O Gruselle… - Clinical Infectious …, 2024 - academic.oup.com
Background The adjuvanted RSV prefusion F protein–based vaccine (RSVPreF3 OA) was
efficacious against RSV-related lower respiratory tract disease (RSV-LRTD) in ≥60-years-…